Buy or sell Proof Diagnostics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Proof Diagnostics Stock

Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.

About Proof Diagnostics Stock

Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.

Funding History

April 2022$45.0M

Management

Co-Founder

Feng Zhang

Co-Founder

Jonathan Gootenberg

Co-Founder

Omar Abudayyeh

Chief Operating Officer

Brian Mitchell

Co-Founder & CEO

Siddharth Shenai

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo